| scholarly article | Q13442814 |
| P2093 | author name string | Dan-Ning Hu | |
| Richard B Rosen | |||
| Nicole K Scripsema | |||
| P2860 | cites work | Lutein effect on retina and hippocampus of diabetic mice. | Q48436671 |
| Lutein and zeaxanthin supplementation in preterm infants to prevent retinopathy of prematurity: a randomized controlled study. | Q50268928 | ||
| Effect of carotenoid supplementation on plasma carotenoids, inflammation and visual development in preterm infants | Q84562421 | ||
| A prospective, randomized, double blind study comparing lutein to placebo for reducing occurrence and severity of retinopathy of prematurity | Q84977347 | ||
| A double-blind, placebo-controlled study on the effects of lutein and zeaxanthin on photostress recovery, glare disability, and chromatic contrast | Q86174589 | ||
| A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8 | Q24544001 | ||
| A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9 | Q24546140 | ||
| Fruits and vegetables that are sources for lutein and zeaxanthin: the macular pigment in human eyes | Q24673347 | ||
| Biochemistry and molecular cell biology of diabetic complications | Q28131781 | ||
| The Relationship of Dietary Carotenoid and Vitamin A, E, and C Intake With Age-Related Macular Degeneration in a Case-Control Study | Q28248143 | ||
| Lipid composition of the human eye: are red blood cells a good mirror of retinal and optic nerve fatty acids? | Q28482205 | ||
| Carotenoids in the human macula and whole retina | Q28609504 | ||
| The pathobiology of diabetic complications: a unifying mechanism | Q29617766 | ||
| Lutein and zeaxanthin as protectors of lipid membranes against oxidative damage: the structural aspects. | Q30583540 | ||
| Resonance Raman measurement of macular carotenoids in normal subjects and in age-related macular degeneration patients | Q30858951 | ||
| Relation among serum and tissue concentrations of lutein and zeaxanthin and macular pigment density | Q31389893 | ||
| Macular pigment and risk for age-related macular degeneration in subjects from a Northern European population | Q31830839 | ||
| Identification and quantitation of carotenoids and their metabolites in the tissues of the human eye. | Q31951685 | ||
| Macular pigment optical density and photophobia light threshold | Q33262832 | ||
| Macular pigment optical density measured by dual-wavelength autofluorescence imaging in diabetic and nondiabetic patients: a comparative study. | Q33588463 | ||
| Lipid and protein oxidation in newborn infants after lutein administration | Q33614323 | ||
| Carotenoids and gene regulation. | Q33706604 | ||
| Neurodegenerative influence of oxidative stress in the retina of a murine model of diabetes | Q33773287 | ||
| Antioxidant intake and risk of incident age-related nuclear cataracts in the Beaver Dam Eye Study | Q33860147 | ||
| A prospective study of carotenoid and vitamin A intakes and risk of cataract extraction in US women | Q33875244 | ||
| A prospective study of carotenoid intake and risk of cataract extraction in US men. | Q33875247 | ||
| Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial). | Q33977885 | ||
| Understanding retinopathy of prematurity: update on pathogenesis | Q34038976 | ||
| The role of oxidative stress in the pathogenesis of age-related macular degeneration. | Q34060719 | ||
| The influence of dietary lutein and zeaxanthin on visual performance | Q34116854 | ||
| Lutein and zeaxanthin intake and the risk of age-related macular degeneration: a systematic review and meta-analysis. | Q34214289 | ||
| A double-blind, placebo-controlled study on the effects of lutein and zeaxanthin on neural processing speed and efficiency | Q34252798 | ||
| Correspondence between retinal reflectometry and a flicker-based technique in the measurement of macular pigment spatial profiles. | Q43199304 | ||
| Beneficial effect of docosahexanoic acid and lutein on retinal structural, metabolic, and functional abnormalities in diabetic rats | Q43230861 | ||
| Macular pigment in donor eyes with and without AMD: a case-control study. | Q43514008 | ||
| Macular pigments lutein and zeaxanthin as blue light filters studied in liposomes | Q43661761 | ||
| Use of vitamin supplements and cataract: the Blue Mountains Eye Study | Q43662311 | ||
| Long-term nutrient intake and early age-related nuclear lens opacities | Q43670254 | ||
| Plasma antioxidant vitamins and carotenoids and age-related cataract | Q43802240 | ||
| Macular pigment density and age-related maculopathy in the Carotenoids in Age-Related Eye Disease Study. An ancillary study of the women's health initiative | Q43881495 | ||
| Distribution of individual macular pigment carotenoids in central retina of macaque and squirrel monkeys | Q43943170 | ||
| Carotenoid triplet states in reaction centers from Rhodopseudomonas sphaeroides and Rhodospirillum rubrum | Q43953222 | ||
| Lens aging in relation to nutritional determinants and possible risk factors for age-related cataract. | Q44241367 | ||
| Lutein, but not alpha-tocopherol, supplementation improves visual function in patients with age-related cataracts: a 2-y double-blind, placebo-controlled pilot study | Q44266631 | ||
| Plasma carotenoids and diabetic retinopathy | Q44337951 | ||
| Aging of cultured retinal pigment epithelial cells: oxidative reactions, lipofuscin formation and blue light damage | Q44390194 | ||
| Lutein and zeaxanthin status and risk of age-related macular degeneration. | Q44453108 | ||
| Action spectrum for photophobia | Q44625949 | ||
| Improvement of retinal function in early age-related macular degeneration after lutein and zeaxanthin supplementation: a randomized, double-masked, placebo-controlled trial | Q44696848 | ||
| Carotenoid, tocopherol, and retinol concentrations in elderly human brain. | Q44885353 | ||
| Spatial properties of photophobia | Q45081409 | ||
| Lutein and zeaxanthin and the risk of cataract: the Melbourne visual impairment project | Q45163501 | ||
| Central role of PKCdelta in glycoxidation-dependent apoptosis of human neurons | Q45303925 | ||
| The effects of a lutein-based supplement on objective and subjective measures of retinal and visual function in eyes with age-related maculopathy -- a randomised controlled trial | Q45683269 | ||
| Cellular and vascular changes in the retina of neonatal rats after an acute exposure to hypoxia. | Q45993787 | ||
| Measurement of carotenoids in human and monkey retinas | Q46055420 | ||
| CFF thresholds: relation to macular pigment optical density | Q46543569 | ||
| Cognitive findings of an exploratory trial of docosahexaenoic acid and lutein supplementation in older women. | Q46568948 | ||
| Beneficial effect of zeaxanthin on retinal metabolic abnormalities in diabetic rats | Q46667364 | ||
| Macular pigment and visual performance under glare conditions | Q46736128 | ||
| Photooxidation of A2-PE, a photoreceptor outer segment fluorophore, and protection by lutein and zeaxanthin | Q46858619 | ||
| Causes and prevalence of visual impairment among adults in the United States | Q46890945 | ||
| Oxidative stress in a model of experimental diabetic retinopathy: the utility of peroxinytrite scavengers | Q46921998 | ||
| Lutein and zeaxanthin supplementation in preterm very low-birth-weight neonates in neonatal intensive care units: a multicenter randomized controlled trial | Q47299072 | ||
| Measurement of carotenoids, retinoids, and tocopherols in human lenses. | Q34290201 | ||
| Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group | Q34323879 | ||
| Stereochemistry of the human macular carotenoids. | Q34364881 | ||
| Distribution of lutein and zeaxanthin stereoisomers in the human retina | Q34428109 | ||
| Macular response to supplementation with differing xanthophyll formulations in subjects with and without age-related macular degeneration | Q34443359 | ||
| Lutein and zeaxanthin supplementation and association with visual function in age-related macular degeneration | Q34454169 | ||
| Sustained supplementation and monitored response with differing carotenoid formulations in early age-related macular degeneration | Q34476425 | ||
| Dietary intake of antioxidants and risk of age-related macular degeneration | Q34479951 | ||
| Macular pigment response to a supplement containing meso-zeaxanthin, lutein and zeaxanthin | Q34627818 | ||
| Carotenoids in Age-related Maculopathy Italian Study (CARMIS): two-year results of a randomized study | Q34633116 | ||
| Dietary antioxidants and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study | Q34657635 | ||
| Long-term effects of vitamins C and E, β-carotene, and zinc on age-related macular degeneration: AREDS report no. 35. | Q34666874 | ||
| Lycopene as the most efficient biological carotenoid singlet oxygen quencher | Q34680390 | ||
| Long term effects of lutein, zeaxanthin and omega-3-LCPUFAs supplementation on optical density of macular pigment in AMD patients: the LUTEGA study | Q34733171 | ||
| The role of carotenoids in human health | Q34756115 | ||
| Carotenoids in the retina--a review of their possible role in preventing or limiting damage caused by light and oxygen | Q35541647 | ||
| Nutritional and clinical relevance of lutein in human health | Q35545380 | ||
| Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3 | Q36257030 | ||
| Role of poly(ADP-ribose) polymerase-1 activation in the pathogenesis of diabetic complications: endothelial dysfunction, as a common underlying theme | Q36342643 | ||
| Oxidative-nitrosative stress and poly(ADP-ribose) polymerase (PARP) activation in experimental diabetic neuropathy: the relation is revisited | Q36431827 | ||
| Risk factors for age-related maculopathy are associated with a relative lack of macular pigment | Q36644163 | ||
| Dietary carotenoids, vitamins C and E, and risk of cataract in women: a prospective study. | Q36676798 | ||
| Retinal sensitivity to damage from short wavelength light | Q36747411 | ||
| Prospective study of lutein/zeaxanthin intake and risk of age-related macular degeneration | Q36825090 | ||
| Macular lutein and zeaxanthin are related to brain lutein and zeaxanthin in primates | Q37300459 | ||
| Macular pigment optical density is related to cognitive function in older people | Q37590781 | ||
| The pathophysiology of retinopathy of prematurity: an update of previous and recent knowledge | Q38101684 | ||
| The biology of retinopathy of prematurity: how knowledge of pathogenesis guides treatment | Q38110390 | ||
| Role of macular xanthophylls in prevention of common neovascular retinopathies: retinopathy of prematurity and diabetic retinopathy | Q38363355 | ||
| Effect of lutein and zeaxanthin on macular pigment and visual function in patients with early age-related macular degeneration | Q39575237 | ||
| PKC delta and NADPH oxidase in AGE-induced neuronal death | Q40167891 | ||
| Biological activities of natural and synthetic carotenoids: induction of gap junctional communication and singlet oxygen quenching. | Q41140948 | ||
| Carotenoids and intercellular communication via gap junctions | Q41626725 | ||
| Application of Lutein and Zeaxanthin in nonproliferative diabetic retinopathy | Q42132173 | ||
| Density of the human crystalline lens is related to the macular pigment carotenoids, lutein and zeaxanthin | Q42547749 | ||
| The effect of macular pigment on heterochromatic luminance contrast | Q42872808 | ||
| Macular pigment optical density in an ageing Irish population: The Irish Longitudinal Study on Ageing. | Q43047847 | ||
| Relationships between macular pigment optical density and cognitive function in unimpaired and mildly cognitively impaired older adults. | Q50660883 | ||
| Low macular pigment optical density is associated with lower cognitive performance in a large, population-based sample of older adults. | Q50704945 | ||
| Sex differences in macular pigment optical density: relation to plasma carotenoid concentrations and dietary patterns. | Q51016525 | ||
| Arterial cord blood lutein levels in preterm and term healthy newborns are sex and gestational age dependent. | Q51318548 | ||
| Lutein supplementation over a one-year period in early AMD might have a mild beneficial effect on visual acuity: the CLEAR study. | Q53121765 | ||
| Secondary outcomes in a clinical trial of carotenoids with coantioxidants versus placebo in early age-related macular degeneration. | Q53129620 | ||
| Antioxidant activity of xanthophylls on peroxyl radical-mediated phospholipid peroxidation. | Q54268088 | ||
| Effect of a water-soluble vitamin E analog, trolox C, on retinal vascular development in an animal model of retinopathy of prematurity. | Q54466695 | ||
| The use of vitamin supplements and the risk of cataract among US male physicians. | Q55065980 | ||
| Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group | Q56534843 | ||
| Carotenoid scavenging of radicals | Q57237483 | ||
| Carotenoid protection against oxidation | Q57485951 | ||
| Lutein, zeaxanthin, meso-zeaxanthin content in egg yolk and their absence in fish and seafood | Q57567893 | ||
| Retinopathy of prematurity | Q60439193 | ||
| Effects of Lutein Supplementation on Macular Pigment Optical Density and Visual Acuity in Patients with Age-Related Macular Degeneration | Q60699438 | ||
| Serum Antioxidants and Age-Related Macular Degeneration in a Population-Based Case-Control Study | Q63339752 | ||
| Associations Between Intermediate Age-Related Macular Degeneration and Lutein and Zeaxanthin in the Carotenoids in Age-Related Eye Disease Study (CAREDS) | Q63344335 | ||
| Reducing the Genetic Risk of Age-Related Macular Degeneration With Dietary Antioxidants, Zinc, and ω-3 Fatty Acids | Q64461561 | ||
| The topography and age relationship of lipofuscin concentration in the retinal pigment epithelium | Q67355361 | ||
| Dietary essential fatty acid supply and visual acuity development | Q67906847 | ||
| The Lens Opacities Case-Control Study. Risk factors for cataract | Q68193002 | ||
| Analysis of the macular pigment by HPLC: retinal distribution and age study | Q68367274 | ||
| Plasma carotenoids in normal men after a single ingestion of vegetables or purified beta-carotene | Q69623696 | ||
| Preliminary identification of the human macular pigment | Q69790666 | ||
| Aging human RPE: morphometric analysis of macular, equatorial, and peripheral cells | Q71275163 | ||
| The macular pigment. II. Spatial distribution in primate retinas | Q71356053 | ||
| Foveal flicker sensitivity in healthy aging eyes. II. Cross-sectional aging trends from 18 through 77 years of age | Q72153335 | ||
| The Linxian cataract studies. Two nutrition intervention trials | Q72907785 | ||
| Interaction of oxygen and oxy-radicals with carotenoids | Q72937053 | ||
| Lutein and zeaxanthin are associated with photoreceptors in the human retina | Q73154792 | ||
| Fat-soluble nutrient concentrations in different layers of human cataractous lens | Q73154795 | ||
| Vitamin supplement use and incident cataracts in a population-based study | Q73180593 | ||
| Therapeutic effect of liposomal superoxide dismutase in an animal model of retinopathy of prematurity | Q73298393 | ||
| Antioxidant vitamins and nuclear opacities: the longitudinal study of cataract | Q74566532 | ||
| Associations between antioxidant and zinc intake and the 5-year incidence of early age-related maculopathy in the Beaver Dam Eye Study | Q74805233 | ||
| Rate constants for quenching singlet oxygen and activities for inhibiting lipid peroxidation of carotenoids and alpha-tocopherol in liposomes | Q77198818 | ||
| Comments on the use of Raman spectroscopy for the in vivo measurement of human macular pigment | Q79389416 | ||
| The glare hypothesis of macular pigment function | Q81304766 | ||
| The impact of macular pigment augmentation on visual performance in normal subjects: COMPASS | Q83211085 | ||
| Macular pigment and visual performance in glare: benefits for photostress recovery, disability glare, and visual discomfort | Q83377582 | ||
| Plasma lutein and zeaxanthin and other carotenoids as modifiable risk factors for age-related maculopathy and cataract: the POLA Study | Q83839560 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | eye disease | Q3041498 |
| P304 | page(s) | 865179 | |
| P577 | publication date | 2015-01-01 | |
| P1433 | published in | Journal of Ophthalmology | Q26842872 |
| P1476 | title | Lutein, Zeaxanthin, and meso-Zeaxanthin in the Clinical Management of Eye Disease | |
| P478 | volume | 2015 |
| Q58702202 | Complement System and Age-Related Macular Degeneration: Implications of Gene-Environment Interaction for Preventive and Personalized Medicine |
| Q64930030 | Effect of Long-Term Xanthophyll and Anthocyanin Supplementation on Lutein and Zeaxanthin Serum Concentrations and Macular Pigment Optical Density in Postmenopausal Women. |
| Q47096013 | Effects of the Macular Carotenoid Lutein in Human Retinal Pigment Epithelial Cells |
| Q39486132 | In Vitro Inhibition of Human UDP-Glucuronosyl-Transferase (UGT) Isoforms by Astaxanthin, β-Cryptoxanthin, Canthaxanthin, Lutein, and Zeaxanthin: Prediction of in Vivo Dietary Supplement-Drug Interactions. |
| Q60950469 | Lutein and Zeaxanthin Isomers Reduce Photoreceptor Degeneration in the Mouse Model of Retinitis Pigmentosa |
| Q41111119 | Lutein and zeaxanthin isomers modulates lipid metabolism and the inflammatory state of retina in obesity-induced high-fat diet rodent model. |
| Q52588804 | Lutein, zeaxanthin and mammalian development: Metabolism, functions and implications for health. |
| Q37673168 | Lutein and Zeaxanthin-Food Sources, Bioavailability and Dietary Variety in Age-Related Macular Degeneration Protection |
| Q55491304 | Macular pigment and serum zeaxanthin levels with Goji berry supplement in early age-related macular degeneration. |
| Q64897018 | Mechanisms of Carotenoid Intestinal Absorption: Where Do We Stand? |
| Q55113695 | Modulatory Effect of Carotenoid Supplement Constituting Lutein and Zeaxanthin (10:1) on Anti-oxidant Enzymes and Macular Pigments Level in Rats. |
| Q48235423 | Negative effects of divalent mineral cations on the bioaccessibility of carotenoids from plant food matrices and related physical properties of gastro-intestinal fluids. |
| Q64997207 | Nutraceuticals for the Treatment of Diabetic Retinopathy. |
| Q58613181 | Nutritional Composition and Bioactive Content of Legumes: Characterization of Pulses Frequently Consumed in France and Effect of the Cooking Method |
| Q43113335 | Protective Effects of Oral Astaxanthin Nanopowder against Ultraviolet-Induced Photokeratitis in Mice. |
| Q38692816 | The Pharmacological Effects of Lutein and Zeaxanthin on Visual Disorders and Cognition Diseases. |
Search more.